Exploration into the lipid management and persistent risk in the patients hospitalized for acute coronary syndrome in Japan

Exploration into the lipid management and persistent risk in the patients hospitalized for acute coronary syndrome in Japan - Exploration into the lipid management and persistent risk in the patients hospitalized for acute coronary syndrome (EXPLORE-J)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018946

Enrollment

2000

Registered

2015-10-02

Start date

2015-04-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome (ACS)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients hospitalized for any ACS (Acute ST-segment elevation myocardial infarction: STEMI, Acute non ST-segment elevation myocardial infarction: NSTEMI, Unstable angina :UA) 2)Patients aged equal or over 20 years 3)Written informed consent

Exclusion criteria

Exclusion criteria: 1) ACS accompanied by or precipitated by significant comorbidity. 2) Enrolled other lipid interventional studies 3) Patients with sub-acute stent-thrombosis caused by revascularization procedures.

Design outcomes

Primary

Measure	Time frame
The persistent risk will be defined as the incidence of major adverse cardiovascular events (MACE)	—

Secondary

Measure	Time frame
[1] Coronary revascularization based on myocardial ischemia#2 [2] Revascularization excluding the heart [3] Inpatient treatment due to occurrence or exacerbation of heart failure [4] Transient ischemic attack (TIA)#3 [5] Acute arterial obstruction [6] Central retinal artery occlusion [7] Other adverse events prolonging or requiring hospitalization	—

Countries

Japan

Contacts

Public ContactHiroichi Yamamoto

Mebix EXPLORE-J office

explore-j@mebix.co.jp03-4362-4504

Outcome results